The role of cell-free DNA in fibrinolysis for intraventricular hemorrhage

被引:6
|
作者
Xie, Fangke [1 ]
Tan, Qiang [2 ]
Yu, Anyong [1 ]
Guo, Peiwen [2 ]
Wang, Ling [2 ]
Zeng, Zongwei [2 ]
Liang, Liang [2 ]
Xian, Jishu [2 ]
Feng, Hua [2 ]
Chen, Zhi [2 ]
机构
[1] Zunyi Med Univ, Affiliated Hosp, Dept Emergency, Zunyi, Peoples R China
[2] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
intraventricular hemorrhage; tissue plasminogen activator; neutrophil extracellular traps; cell-free DNA; fibrinolysis; vascular disorders; NEUTROPHIL EXTRACELLULAR TRAPS; TISSUE-PLASMINOGEN ACTIVATOR; CITRULLINATED HISTONE H3; CANINE MODEL; BLOOD-CLOT; UROKINASE; HEMATOMA; LYSIS; THERAPY;
D O I
10.3171/2020.7.JNS201429
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Tissue plasminogen activator (tPA) fibrinolysis did not improve functional outcomes of patients with intraventricular hemorrhage (IVH), largely because of the unsatisfactory clot clearance. The presence of neutrophil extracellular traps (NETs) within the clot has been confirmed to impair tPA fibrinolysis, but the mechanism has been unclear. The authors hypothesized that cell-free DNA (cfDNA), the main framework of NETs, might be the important reason for the fibrinolysis resistance, and they validated the hypothesis, hoping to provide a new target to promote intraventricular fibrinolysis. METHODS First, cfDNA was detected in IVH clots by immunofluorescence staining in a rat model of IVH. Second, after blood (with or without exogenous cfDNA) intraventricular injection, IVH rats were given intraventricular infusion of 2 mu l of saline, tPA, or tPA + DNase1 randomly. Then, the ventricular volume, animal behavior, and reactive astrocyte proliferation were assessed. Third, the IVH clots were collected for fibrinolysis assay in vitro. Finally, the effects of exogenous cfDNA in IVH were evaluated. RESULTS The presence of cfDNA in clots was observed as early as 1 hour after IVH. Compared with the whole-blood model, blood + cfDNA caused more severe ventricular dilation (day 7: blood 32.47 +/- 2.096 mm(3) vs blood + DNA 40.09 +/- 2.787 mm(3), p < 0.05), increased fibrinolysis resistance to tPA (day 7: tPA + DNA 26.04 +/- 1.318 mm(3) vs tPA 22.15 +/- 1.706 mm(3), p < 0.05), and further deteriorated the functional defects in rats (blood vs blood + DNA, p < 0.05). Degradation of cfDNA by DNase1 further enhanced the fibrinolysis effects on relieving the ventricular dilation (day 7: tPA + DNase1 11.67 +/- 2.023 mm(3) vs tPA, p < 0.05), improving the functional outcome (tPA vs tPA + DNase1, p < 0.05) and reducing periventricular astrocyte proliferation. CONCLUSIONS cfDNA impaired tPA fibrinolysis for IVH, and degradation of cfDNA may be a new target to improve this condition.
引用
收藏
页码:1105 / 1112
页数:8
相关论文
共 50 条
  • [31] Effects of cell-free DNA on kidney disease and intervention strategies
    Zhang, Mingying
    Cai, Yubin
    Zhong, Xiaoze
    Liu, Weijun
    Lin, Yuan
    Qiu, Zhanyi
    Liang, Ruihuang
    Wei, Huibo
    Wu, Kefei
    Liu, Qinghua
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] Treatment of Intraventricular Hemorrhage with External Ventricular Drainage and Fibrinolysis: A Comprehensive Systematic Review and Meta-Analysis of Complications and Outcome
    Haldrup, Mette
    Miscov, Rares
    Mohamad, Niwar
    Rasmussen, Mads
    Dyrskog, Stig
    Simonsen, Claus Ziegler
    Gronhoj, Mads
    Poulsen, Frantz Rom
    Bjarkam, Carsten Reidies
    Debrabant, Birgit
    Korshoj, Anders Rosendal
    WORLD NEUROSURGERY, 2023, 174 : 183 - +
  • [33] Intraventricular Fibrinolysis for Intracerebral Hemorrhage with Severe Ventricular Involvement
    Dimitre Staykov
    Juergen Bardutzky
    Hagen B. Huttner
    Stefan Schwab
    Neurocritical Care, 2011, 15 : 194 - 209
  • [34] The role of cell-free DNA in predicting colorectal cancer prognosis
    Cao, Bo
    Zhou, Xin
    Yang, Wanli
    Ma, Jiaojiao
    Zhou, Wei
    Fan, Daiming
    Hong, Liu
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (01) : 39 - 48
  • [35] Risk Factors for Poor Outcome in Hypertensive Intraventricular Hemorrhage Treated by External Ventricular Drainage with Intraventricular Fibrinolysis
    Fu, Chuhua
    Liu, Lijun
    Chen, Bo
    Wang, Ning
    Tan, Zhibin
    Chen, Huayun
    Liu, Xiao
    Dang, Yanwei
    WORLD NEUROSURGERY, 2017, 102 : 240 - 245
  • [36] Role of Cell-Free DNA in Relapsed Head and Neck Cancer
    Baa, Annie Kanchan
    Sharma, Atul
    Singh, Mayank
    Gupta, Ashna
    Biswas, Ahitagni
    Bharti, Sacchidanand Jee
    Thakar, Alok
    Kumar, Rajeev
    Pramanik, Raja
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2025, 46 (01) : 87 - 92
  • [37] Plasma Cell-Free DNA as a Novel Biomarker for the Diagnosis and Monitoring of Atherosclerosis
    Qian, Benheng
    Li, Kexin
    Lou, Xiaoying
    Guo, Ye
    Wang, Yidong
    Wu, Lianpin
    Zhang, Donghong
    CELLS, 2022, 11 (20)
  • [38] Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives
    Glebova, Kristina V.
    Veiko, Natalya N.
    Nikonov, Aleksey A.
    Porokhovnik, Lev N.
    Kostuyk, Svetlana V.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2018, 55 (01) : 55 - 70
  • [39] Elevated Pro-Inflammatory Cell-Free MicroRNA Levels in Cerebrospinal Fluid of Premature Infants after Intraventricular Hemorrhage
    Fejes, Zsolt
    Erdei, Judit
    Pocsi, Marianna
    Takai, Jun
    Jeney, Viktoria
    Nagy, Andrea
    Varga, Aliz
    Bacsi, Attila
    Bognar, Laszlo
    Novak, Laszlo
    Kappelmayer, Janos
    Nagy, Bela, Jr.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 20
  • [40] Properties and Application of Cell-Free DNA as a Clinical Biomarker
    de Miranda, Felipe Silva
    Barauna, Valerio Garrone
    dos Santos, Leandro
    Costa, Gustavo
    Vassallo, Paula Frizera
    Campos, Luciene Cristina Gastalho
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)